Thromb Haemost 1981; 46(01): 185
DOI: 10.1055/s-0038-1652524
Heparin – III: Fractions, Analogues, Antithrombotic Effects
Heparin – IV: Antithrombins, Antithrombotic Effects, Antibody
Schattauer GmbH Stuttgart

Kinetics Of Anticoagulant And Lipolytic Activity And Radiolabel After Intravenous Administration Of 35S-Heparin Fractions Of Different Molecular Weight

C A M de Swart
Department of Hematology, State University Utrecht, The Netherlands
,
J J Sixma
Department of Hematology, State University Utrecht, The Netherlands
,
A Nijmeijer
Department of Hematology, State University Utrecht, The Netherlands
AB KABI Research, Department of Biochemistry, Stockholm, Sweden
Department of Internal Medicine, State University Hospital “Dijkzigt”, Rotterdam, The Netherlands
,
E Holmer
Department of Hematology, State University Utrecht, The Netherlands
AB KABI Research, Department of Biochemistry, Stockholm, Sweden
Department of Internal Medicine, State University Hospital “Dijkzigt”, Rotterdam, The Netherlands
,
L O Andersson
Department of Hematology, State University Utrecht, The Netherlands
AB KABI Research, Department of Biochemistry, Stockholm, Sweden
Department of Internal Medicine, State University Hospital “Dijkzigt”, Rotterdam, The Netherlands
,
L Verschoor
Department of Hematology, State University Utrecht, The Netherlands
AB KABI Research, Department of Biochemistry, Stockholm, Sweden
Department of Internal Medicine, State University Hospital “Dijkzigt”, Rotterdam, The Netherlands
› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Heparin fractions were prepared from commercial pig mucosal by affinity chromatography on antithrombin III, 35S- radiolabelling and gelchromatography. Three fractions were obtained with moLwt.of < 6.000, 6 - 35.000 and > 35.000 daltons. They were administered intravenous as a bolus into human volunteers. The anticoagulant activity was measured with the APTT and Xa inactivation, using standard curves. The lipolytic activity was as^ed as hepatic triglyceride lipase activity, and as extra-hepatic lipoprotein lipase activity by hydrolysis of tritiated triolein. Radioactivity data were corrected for degraded heparin fragments uncomplexed to protein by subtracting radiolabel with a mol.wt. < 10.000 passing through a filter.

Low mol.wt. fractions induced neither of both lipase activity and had no effect on the APTT. Anti Xa activity and radioactivity disappeared in parallel with slightly concave curves in semilogarthmic plots. Heparin of intermediate and high mol.wt. induced both lipolytic and both anticoagulant activities. The elimination of radioactivity, hepatic triglyceride lipase activity and anti-Xa activity occurred parallel according to a convex curve in semilogarthmic plots. The extra-hepatic lipoprotein lipase activity disappeared following a slightly concave curve.

These data indicate that relatively large heparin molecules are required for lipolytic and APTT activity. Hepatic triglyceride lipase activity might be present complexed to heparin, comparable to the antithrombin III-heparin complex. The elimination of anti Xa activity and hepatic triglyceride lipase activity might be determined by the heparin part of the complexes.